HASI SNP genotype associates with risk of B-cell malignancy*.

*All comparisons are of case subjects with control subjects. All groups met Hardy Weinberg Equilibrium. Allelic odds ratios and the corresponding 95% confidence intervals were calculated for the association analysis and are shown in the table. CI denotes confidence interval, OR denotes odds ratio. The genome position is based on the National Centre for Biotechnology Information database. For CLL samples, a cohort of 20 patients provided both enriched B cells and buccal cells; both populations gave identical results. No assumptions were made about the effect of the SNPs prior to analysis.